Chintan Shivir in Ahmedabad focuses on scaling pharma exports as India crosses $30 billion mark

• Chintan Shivir industry interaction on theme "Scaling up Pharma Exports" held in Ahmedabad on 21 Feb 2026 by the Department of Commerce with PHARMEXCIL.
• Convened against the milestone of India's pharma exports crossing USD 30 billion (USD 30.47 bn in FY 2024-25, +9.4% YoY); industry target = double-digit growth in 2026-27.
• Flagged the ₹10,000 crore Biopharma SHAKTI initiative to build biologics/biosimilars capacity and cut import dependence.
• Examinable as a GS-III economy/industry hook bridging PLI-Pharma, biotech policy, trade diplomacy and India's "Pharmacy of the World" branding.